Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Addex Therapeutics Ltd.

  • Public · NASDAQ: ADXN
  • 3 employees
$7.4MMarket cap
3Employees
ADXNNASDAQ
2020IPO

About Addex Therapeutics Ltd.

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$7.4M
NASDAQ: ADXN

15-minute delayed · data by Polygon.io

Market cap
$7.4M
Open
Day range
Prev close
Volume
IPO date
Jan 29, 2020

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Addex Therapeutics Ltd..

Write a review
Explore

Similar companies

Browse all →